278 related articles for article (PubMed ID: 17116295)
1. A new ATP-sensitive potassium channel opener protects endothelial function in cultured aortic endothelial cells.
Wang H; Long C; Duan Z; Shi C; Jia G; Zhang Y
Cardiovasc Res; 2007 Feb; 73(3):497-503. PubMed ID: 17116295
[TBL] [Abstract][Full Text] [Related]
2. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
[TBL] [Abstract][Full Text] [Related]
3. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
Misaki N; Mao X; Lin YF; Suga S; Li GH; Liu Q; Chang Y; Wang H; Wakui M; Wu J
J Pharmacol Exp Ther; 2007 Aug; 322(2):871-8. PubMed ID: 17522344
[TBL] [Abstract][Full Text] [Related]
4. Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats.
Yang Y; Liu X; Long Y; Wang F; Ding JH; Liu SY; Sun YH; Yao HH; Wang H; Wu J; Hu G
J Neurosci Res; 2005 May; 80(3):442-9. PubMed ID: 15795934
[TBL] [Abstract][Full Text] [Related]
5. Iptakalim inhibited endothelin-1-induced proliferation of human pulmonary arterial smooth muscle cells through the activation of K(ATP) channel.
Zhu Y; Zhang S; Xie W; Li Q; Zhou Y; Wang H
Vascul Pharmacol; 2008; 48(2-3):92-9. PubMed ID: 18276195
[TBL] [Abstract][Full Text] [Related]
6. Chemerin/ChemR23 signaling axis is involved in the endothelial protection by K(ATP) channel opener iptakalim.
Zhao RJ; Wang H
Acta Pharmacol Sin; 2011 May; 32(5):573-80. PubMed ID: 21516134
[TBL] [Abstract][Full Text] [Related]
7. ATP-sensitive potassium channel opener iptakalim protected against the cytotoxicity of MPP+ on SH-SY5Y cells by decreasing extracellular glutamate level.
Hu LF; Wang S; Shi XR; Yao HH; Sun YH; Ding JH; Liu SY; Hu G
J Neurochem; 2005 Sep; 94(6):1570-9. PubMed ID: 16000145
[TBL] [Abstract][Full Text] [Related]
8. Anti-proliferating effect of iptakalim, a novel KATP channel opener, in cultured rabbit pulmonary arterial smooth muscle cells.
Xie W; Wang H; Ding J; Wang H; Hu G
Eur J Pharmacol; 2005 Mar; 511(2-3):81-7. PubMed ID: 15792775
[TBL] [Abstract][Full Text] [Related]
9. Large-conductance K+ channel opener CGS7184 as a regulator of endothelial cell function.
Wrzosek A; Łukasiak A; Gwóźdź P; Malińska D; Kozlovski VI; Szewczyk A; Chlopicki S; Dołowy K
Eur J Pharmacol; 2009 Jan; 602(1):105-11. PubMed ID: 19028489
[TBL] [Abstract][Full Text] [Related]
10. Iptakalim modulates ATP-sensitive K(+) channels in dopamine neurons from rat substantia nigra pars compacta.
Wu J; Hu J; Chen YP; Takeo T; Suga S; Dechon J; Liu Q; Yang KC; St John PA; Hu G; Wang H; Wakui M
J Pharmacol Exp Ther; 2006 Oct; 319(1):155-64. PubMed ID: 16837559
[TBL] [Abstract][Full Text] [Related]
11. The new antihypertensive drug iptakalim activates ATP-sensitive potassium channels in the endothelium of resistance blood vessels.
Wang SY; Cui WY; Wang H
Acta Pharmacol Sin; 2015 Dec; 36(12):1444-50. PubMed ID: 26592519
[TBL] [Abstract][Full Text] [Related]
12. The molecular site of action of K(ATP) channel inhibitors determines their ability to inhibit iNOS-mediated relaxation in rat aorta.
Wilson AJ; Clapp LH
Cardiovasc Res; 2002 Oct; 56(1):154-63. PubMed ID: 12237176
[TBL] [Abstract][Full Text] [Related]
13. Targeting hypertension with a new adenosine triphosphate-sensitive potassium channel opener iptakalim.
Pan Z; Huang J; Cui W; Long C; Zhang Y; Wang H
J Cardiovasc Pharmacol; 2010 Sep; 56(3):215-28. PubMed ID: 20410832
[TBL] [Abstract][Full Text] [Related]
14. Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats.
Yang Y; Liu X; Long Y; Wang F; Ding JH; Liu SY; Sun YH; Yao HH; Wang H; Wu J; Hu G
Int J Neuropsychopharmacol; 2006 Feb; 9(1):51-61. PubMed ID: 15927086
[TBL] [Abstract][Full Text] [Related]
15. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
16. Cyclovirobuxine D ameliorates acute myocardial ischemia by K(ATP) channel opening, nitric oxide release and anti-thrombosis.
Hu D; Liu X; Wang Y; Chen S
Eur J Pharmacol; 2007 Aug; 569(1-2):103-9. PubMed ID: 17555743
[TBL] [Abstract][Full Text] [Related]
17. Arterial flow induces changes in saphenous vein endothelium proteins transduced by cation channels.
Golledge J; Gosling M; Turner RJ; Standfield NJ; Powell JT
Eur J Vasc Endovasc Surg; 2000 May; 19(5):545-50. PubMed ID: 10828238
[TBL] [Abstract][Full Text] [Related]
18. Activation of SUR2B/Kir6.1-type K(ATP) channels protects glomerular endothelial, mesangial and tubular epithelial cells against oleic acid renal damage.
Zhao Y; Wang H
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Nov; 28(6):572-6. PubMed ID: 23581188
[TBL] [Abstract][Full Text] [Related]
19. Iptakalim protects against hypoxic brain injury through multiple pathways associated with ATP-sensitive potassium channels.
Zhu HL; Luo WQ; Wang H
Neuroscience; 2008 Dec; 157(4):884-94. PubMed ID: 18951957
[TBL] [Abstract][Full Text] [Related]
20. [Interventional effects of activating SUR2B/Kir6.1-type K
Zhao Y; Wang H
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Nov; 38(6):604-610. PubMed ID: 37308403
[No Abstract] [Full Text] [Related]
[Next] [New Search]
